Tuesday, November 14, 2023
- 9:00AM-11:00AM
-
Abstract Number: 2196
Females with Axial Spondyloarthritis Report Higher Burden of Disease and Worse Patient-reported Outcomes. Results from the International Map of Axial Spondyloarthritis (IMAS)
(2195–2226) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: SpA- 9:00AM-11:00AM
-
Abstract Number: 1752
Fibroblast Expression of Neurotransmitter Receptor HTR2A Associates with Inflammation in Rheumatoid Arthritis Joint
(1734–1775) RA – Etiology and Pathogenesis Poster- 9:00AM-11:00AM
-
Abstract Number: 2199
Four-year Secukinumab Treatment Outcomes in Axial Spondyloarthritis and Psoriatic Arthritis Patients Treated in Routine Care: Results from the EuroSpA Collaboration
(2195–2226) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: SpA- 9:00AM-11:00AM
-
Abstract Number: 2339
Fragility of Randomized Clinical Trials of Systemic Lupus Erythematosus and Lupus Nephritis Therapies
(2326–2351) SLE – Treatment Poster III- 9:00AM-11:00AM
-
Abstract Number: 2138
Frailty Is a Predictor of Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis
(2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III- 9:00AM-11:00AM
-
Abstract Number: 2117
Frailty Is Associated with Mortality in Veterans with Rheumatoid Arthritis
(2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III- 9:00AM-11:00AM
-
Abstract Number: 1960
From Clinical Amyopathy to Severe Oropharyngeal Dysphagia in Pure Dermatomyositis: A Greater Extent of Muscle Weakness Is Associated with a Higher Cancer Prevalence
(1945–1972) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III- 9:00AM-11:00AM
-
Abstract Number: 2086
From Fellow to Fellowship Director: Gender Equity in Pediatric Rheumatology Pipeline
(2061–2088) Professional Education Poster- 9:00AM-11:00AM
-
Abstract Number: 2312
Fungal Infections in Hospitalized Patients of Systemic Lupus Erythematosus: A Nationwide Cohort Analysis
(2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III- 9:00AM-11:00AM
-
Abstract Number: 2247
Gender Differences in Switching Biological and Targeted Synthetic Therapies in Psoriatic Arthritis
(2227–2256) Spondyloarthritis Including Psoriatic Arthritis – Treatment: SpA Poster III- 9:00AM-11:00AM
-
Abstract Number: 2217
Gender Disparities in Disease Activity Scores and Treatment Response Among Patients with Axial Spondyloarthritis
(2195–2226) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: SpA- 9:00AM-11:00AM
-
Abstract Number: 2016
Generation of a Human 3D in Vitro Bone Model That Mimics Glucocorticoid-induced Osteoporosis
(1996–2018) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1710
Genetic Associations in Juvenile Idiopathic Arthritis Determined with an Electronic Health Record Based Approach